Please complete this form to report a pregnancy in a patient (or in a female partner of a male patient) treated with lenalidomide. Please email immediately to Te Arai BioFarma. 

As part of Te Arai BioFarma’s Safety Monitoring System, it is essential that we follow-up on all reported pregnancies. Te Arai BioFarma will therefore be in contact with you for further information in due course and would value your cooperation to ensure we are able to obtain all relevant information regarding foetal exposure to lenalidomide.

regulatory@tearaibiofarma.com
0800 832 724